Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.90%2.46B | -5.83%2.65B | -4.58%622.55M | -12.90%662.31M | -5.88%681.09M | 1.00%680.77M | -10.02%2.81B | -9.69%652.46M | -5.29%760.38M | -10.60%723.65M |
| Cost of revenue | 6.15%1.43B | -16.55%1.35B | -31.11%322.5M | -12.42%339.4M | -16.54%324.23M | -2.44%360.97M | -16.89%1.61B | -25.10%468.15M | -17.50%387.52M | 1.53%388.5M |
| Gross profit | -20.43%1.03B | 8.63%1.3B | 62.79%300.04M | -13.40%322.91M | 6.48%356.86M | 5.19%319.8M | 1.26%1.2B | 89.23%184.31M | 11.95%372.86M | -21.47%335.15M |
| Operating expense | -5.89%1.17B | -16.23%1.24B | -41.37%296.36M | -1.55%314.28M | -8.35%307.4M | 0.49%322.86M | 9.01%1.48B | 68.96%505.46M | -2.33%319.23M | -15.17%335.39M |
| Staff costs | -7.86%255.81M | 5.63%277.63M | ---- | ---- | ---- | ---- | -3.20%262.82M | ---- | ---- | ---- |
| Selling and administrative expenses | -6.91%651.72M | -26.08%700.09M | ---- | ---- | ---- | ---- | 14.12%947.14M | ---- | ---- | ---- |
| -Selling and marketing expense | -24.24%138.28M | -51.37%182.52M | ---- | ---- | ---- | ---- | 60.50%375.31M | ---- | ---- | ---- |
| -General and administrative expense | -0.80%513.44M | -9.49%517.57M | ---- | ---- | ---- | ---- | -4.08%571.82M | ---- | ---- | ---- |
| Depreciation and amortization | -1.50%1.32M | -33.78%1.34M | ---- | ---- | ---- | ---- | -50.96%2.02M | ---- | ---- | ---- |
| -Depreciation | -1.50%1.32M | -33.78%1.34M | ---- | ---- | ---- | ---- | -50.96%2.02M | ---- | ---- | ---- |
| Rent and land expenses | -0.79%48.98M | 3.24%49.36M | ---- | ---- | ---- | ---- | 10.09%47.81M | ---- | ---- | ---- |
| Other operating expenses | -1.19%209.95M | -4.10%212.48M | ---- | ---- | ---- | ---- | 5.58%221.57M | ---- | ---- | ---- |
| Operating profit | -327.54%-133.61M | 120.60%58.72M | 101.15%3.69M | -83.92%8.62M | 19,962.65%49.46M | 82.29%-3.05M | -60.60%-285.01M | -59.17%-321.14M | 762.51%53.62M | -100.79%-249K |
| Net non-operating interest income (expenses) | -15.42%-51.53M | 5.98%-44.64M | 3.37%-11.13M | 5.30%-11.07M | 8.81%-11.08M | 6.29%-11.36M | -22.26%-47.49M | 5.92%-11.51M | 5.79%-11.69M | -0.87%-12.15M |
| Non-operating interest income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Non-operating interest expense | 15.42%51.53M | -5.98%44.64M | -3.67%11.09M | -5.30%11.07M | -8.53%11.12M | -6.29%11.36M | 19.90%47.49M | -5.92%11.51M | -5.79%11.69M | -5.17%12.15M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 120.93%26.43M | 871.10%11.96M | 1,368.25%12.07M | -23K | 0 | -120.00%-82K | 100.07%1.23M | 100.05%822K | 0 | 0 |
| Less:Other special charges | -120.93%-26.43M | -871.10%-11.96M | -1,368.25%-12.07M | --23K | --0 | 120.00%82K | -104.37%-1.23M | 9.17%-822K | --0 | --0 |
| Other non-operating income (expenses) | -156.36%-23.58M | -13.68%41.84M | -14.21%40.66M | 0.55%364K | 80.27%402K | -15.56%407K | -15.55%48.46M | -16.58%47.4M | 385.04%362K | -22.57%223K |
| Income before tax | -368.61%-182.29M | 124.00%67.86M | 115.92%45.29M | -104.99%-2.11M | 418.38%38.78M | 50.51%-14.09M | 85.61%-282.81M | 85.29%-284.44M | 768.95%42.29M | -157.63%-12.18M |
| Income tax | -15.69%1.29M | 3.31%1.53M | 12.94%419K | 0.27%371K | 0.00%370K | 0.00%370K | 109.28%1.48M | 107.19%371K | -97.57%370K | 103.69%370K |
| Net income | -376.75%-183.58M | 123.33%66.33M | 115.75%44.87M | -105.92%-2.48M | 406.04%38.41M | 49.86%-14.46M | 85.41%-284.29M | 85.37%-284.81M | 1,120.97%41.92M | -140.26%-12.55M |
| Net income continuous operations | -376.75%-183.58M | 123.33%66.33M | 115.75%44.87M | -105.92%-2.48M | 406.05%38.41M | 49.86%-14.46M | 85.41%-284.29M | 85.23%-284.81M | 294.56%41.92M | -140.26%-12.55M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -376.75%-183.58M | 123.33%66.33M | 115.75%44.87M | -105.92%-2.48M | 406.04%38.41M | 49.86%-14.46M | 85.41%-284.29M | 85.37%-284.81M | 1,120.97%41.92M | -140.26%-12.55M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -376.75%-183.58M | 123.33%66.33M | 115.75%44.87M | -105.92%-2.48M | 406.04%38.41M | 49.86%-14.46M | 85.41%-284.29M | 85.37%-284.81M | 1,120.97%41.92M | -140.26%-12.55M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -376.17%-14.485 | 123.42%5.245 | 115.82%3.55 | -106.07%-0.2 | 408.63%3.04 | 49.56%-1.145 | 85.39%-22.395 | 85.34%-22.435 | 1,113.85%3.295 | -140.20%-0.985 |
| Diluted earnings per share | -376.70%-14.485 | 123.38%5.235 | 115.72%3.54 | -106.07%-0.2 | 407.62%3.0363 | 49.56%-1.145 | 85.39%-22.395 | 85.29%-22.5153 | 1,113.85%3.295 | -140.29%-0.987 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |